A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Conditions
Nausea · Vomiting · Drug-Related Side Effects and Adverse Reactions · Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Marin Cancer Care, Greenbrae, California, United States
Contact: Principal Investigator (Cyrus Mazidi)City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States
Contact: Principal Investigator (Sudarsan Kollimuttathuillam)Cancer and Blood Specialty Clinic, Los Alamitos, California, United States
Contact: Principal Investigator (Nihal Abdulla)BASS Cancer Center, Walnut Creek, California, United States
Contact: Principal Investigator (Jewel Johl)UCHealth Harmony, Fort Collins, Colorado, United States
Contact: Principal Investigator (Steven Schuster)Clavis Medical, Miami Lakes, Florida, United States
Contact: Principal Investigator (Eloy Roman)BRCR Global - Tamarac, Tamarac, Florida, United States
Contact: Principal Investigator (Chintan Gandhi)Summit Cancer Care, PC, Savannah, Georgia, United States
Contact: Principal Investigator (Michael Chahin)Hope and Healing Cancer Services, Hinsdale, Illinois, United States
Contact: Principal Investigator (Srilata Gundala)Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
Contact: Principal Investigator (Tarah Ballinger)North Mississippi Hematology and Oncology Associates, Tupelo, Mississippi, United States
Contact: Principal Investigator (Amit Jain)Laura and Isaac Perlmutter Cancer Center, New York, New York, United States
Contact: Principal Investigator (Olivia Seecof)New York Cancer and Blood Specialists, Shirley, New York, United States
Contact: Principal Investigator (Richard Zuniga)Oncology Specialists of Charlotte, Charlotte, North Carolina, United States
Contact: Principal Investigator (Justin Favaro)Southern Oncology Specialists, Huntersville, North Carolina, United States
Contact: Principal Investigator (William Mitchell)Asante Rogue Regional Medical Center, Medford, Oregon, United States
Contact: Principal Investigator (Alison Savage)World Research Link, Baytown, Texas, United States
Contact: Principal Investigator (Amir Rasheed)John Peter Smith Hospital, Fort Worth, Texas, United States
Contact: Principal Investigator (Kalyani Narra)Community Cancer Trials of Utah, Ogden, Utah, United States
Contact: Principal Investigator (Carl Gray)Cancer Care Northwest, Spokane, Washington, United States
Contact: Principal Investigator (Saritha Thumma)Ballarat Health Services, Ballarat Central, Australia
Contact: Principal Investigator (Sharad Sharma)Bendigo Health Care Group, Bendigo, Australia
Contact: Principal Investigator (Danielle Forbes)WA Country Health Service Trial Centre, Perth, Australia
Contact: Principal Investigator (Wei-Sen Lam)Goulburn Valley Health, Shepparton, Australia
Contact: Principal Investigator (Myron Klevansky)Latrobe Regional Health, Traralgon, Australia
Contact: Principal Investigator (Quan Tran)The First People's Hospital of Changde City, Changde, China
Contact: Principal Investigator (Tao Wu)Zhujiang Hospital, Guangzhou, China
Contact: Principal Investigator (Xigang Hu)Zhejiang Provincial People's Hospital, Hangzhou, China
Contact: Principal Investigator (Liu Yang)Jiangmen Center Hospital, Jiangmen, China
Contact: Principal Investigator (XIAOPING LI)The First Affiliated Hospital of Henan University of Science &Technology, Luoyang, China
Contact: Principal Investigator (Jun Yao)Sainte Catherine Institut du Cancer Avignon Provence, Avignon, France
Contact: Principal Investigator (Alma Stancu)Centre Hospitalier d'Annecy, Epagny Metz-Tessy, France
Contact: Principal Investigator (Melodie Carbonnaux)Clinique Victor Hugo Le Mans, Le Mans, France
Contact: Principal Investigator (Yoann Pointreau)Aou Ospedali Riuniti Umberto I, Ancona, Italy
Contact: Principal Investigator (Rossana Berardi)Azienda Ospedaliero Universitaria, Modena, Italy
Contact: Principal Investigator (Roberto Sabbatini)Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
Contact: Principal Investigator (Luca Galli)AULSS8 Berica-Ospedale S.Bortolo, Vicenza, Italy
Contact: Principal Investigator (Maria Vittoria Resi)Himeji Medical Center, Himeji, Japan
Contact: Principal Investigator (Tetsuji Kawamura)The Cancer Institute Hospital of JFCR, Kōtoku, Japan
Contact: Principal Investigator (Naoki Fukuda)Kyoto University Hospital, Kyoto, Japan
Contact: Principal Investigator (TAKAKO NAKAJIMA)Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Japan
Contact: Principal Investigator (Tateaki Naito)SC Memorial Healthcare International SRL, Bucharest, Romania
Contact: Principal Investigator (Ingrid Iordan)Spitalul Clinic Colentina, Bucharest, Romania
Contact: Principal Investigator (Andrei Popescu)Spitalul Clinic Colțea, Bucharest, Romania
Contact: Principal Investigator (Ileana-Raluca Patru)Centrul de Oncologie "Sfântul Nectarie", Craiova, Romania
Contact: Principal Investigator (Michael Schenker)Ovidius Clinical Hospital OCH, Ovidiu, Romania
Contact: Principal Investigator (Laura Mazilu)Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Contact: Principal Investigator (Margarita Majem Tarruella)FutureMeds - Madrid, Madrid, Spain
Contact: Principal Investigator (Esther Holgado)Hospital General Universitario Gregorio Marañon, Madrid, Spain
Contact: Principal Investigator (Silvia Garcia Adrian)Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Contact: Principal Investigator (Imanol Martinez Salas)Hospital de Mataró, Mataró, Spain
Contact: Principal Investigator (Laura Punti Brun)Hospital Universitario Virgen de la Victoria, Málaga, Spain
Contact: Principal Investigator (Jose Carlos Benitez Montañez)Hospital Universitari Sant Joan de Reus, Reus, Spain
Contact: Principal Investigator (Kepa Amillano Parraga)E-Da Cancer Hospital, Kaohsiung City, Taiwan
Contact: Principal Investigator (Kun-Ming Rau)National Cheng Kung University Hospital, Tainan, Taiwan
Contact: Principal Investigator (Chun-Hui Lee)Chi Mei Hospital - Liouying Branch, Tainan, Taiwan
Contact: Principal Investigator (Wen-Tsung Huang)Taipei Veterans General Hospital, Taipei, Taiwan
Contact: Principal Investigator (Muh-Hwa Yang)Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan
Contact: Principal Investigator (Chia-Hsun Hsieh)Adana Medical Park Seyhan Hastanesi, Adana, Turkey (Türkiye)
Contact: Principal Investigator (Ahmet Taner Sumbul)Ankara Bilkent Şehir Hastanesi, Ankara, Turkey (Türkiye)
Contact: Principal Investigator (Mehmet Ali Nahit Sendur)Antalya Egitim ve Arastırma Hastanesi, Antalya, Turkey (Türkiye)
Contact: Principal Investigator (Derya KIVRAK SALIM)Ege Universitesi Hastanesi, Bornova, Turkey (Türkiye)
Contact: Principal Investigator (Tuncay Goksel)Dicle Üniversitesi, Diyarbakır, Turkey (Türkiye)
Contact: Principal Investigator (Muhammet kaplan)Trakya University, Edirne, Turkey (Türkiye)
Contact: Principal Investigator (Muhammet Hacioglu)Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi, Gaziantep, Turkey (Türkiye)
Contact: Principal Investigator (tulay kus)T.C. Sağlik Bakanliği- Marmara Üniversitesi İstanbul Pendik Eğitim Ve Araştirma Hastanesi, Pendik, Turkey (Türkiye)
Contact: Principal Investigator (Ibrahim Bayoglu)Sakarya Training and Research Hospital, Sakarya, Turkey (Türkiye)
Contact: Principal Investigator (Ilhan Hacibekiroglu)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company